SLDB Solid Biosciences Inc.
Healthcare$6.88+0.00%OpenMarket Cap: $536.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.94
P/S
0.00
EV/EBITDA
-1.25
DCF Value
$0.41
FCF Yield
-33.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-74.5%
ROA
-45.3%
ROIC
-49.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-57.3M | $-56.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-49.4M | $-49.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-179.2M | $-174.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-48.1M | $-45.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-41.7M | $-39.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-40.1M | $-39.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-39.9M | $-42.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-129.7M | $-124.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-35.2M | $-32.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-27.8M | $-25.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-26.9M | $-24.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-22.3M | $-20.3M | $-0.70 | — |